20 (AIDX) Notes Payables (2025 - 2026)
20's (AIDX) quarterly Notes Payables came in at $306716.0 in Q1 2026, up 311.09% on a QoQ basis from $74611.0 in Q4 2025.
20 (AIDX) Notes Payables (2025 - 2026) Analysis & Trends
20 (AIDX) has 2 years of Notes Payables data on file, last reported at $306716.0 in Q1 2026.
- Quarterly Notes Payables changed N/A year-over-year to $306716.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $306716.0 (changed N/A YoY) and the FY2025 annual result came in at $74611.0, changed N/A from the prior year.
- Notes Payables advanced to $306716.0 in Q1 2026, from $74611.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $306716.0 in Q1 2026 to a low of $74611.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn |
| 10 | 20 | 5.45 Mn | 905,333.06 | 304,727.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 306,716.00 |
| Dec 31, 2025 | 74,611.00 |